Benedetta di Robilant net worth
Quick answer
Benedetta di Robilant's estimated net worth is $7.5M (range $5.25M – $11.25M) as of 2026. Benedetta di Robilant is Founder at Dorian Therapeutics. Dorian Therapeutics valuation.
Benedetta di Robilant is Founder at Dorian Therapeutics (YC S18). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Acquired
- Education: Ph.D. in Biology from Stanford University
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 8
- Website: http://www.doriantherapeutics.com
Who is Benedetta di Robilant?
Benedetta di Robilant is a co-founder of Dorian Therapeutics, a company focused on advancing the field of cell therapy.
Highlights:
- Stanford University
- Y Combinator S18
- Research in therapeutic solutions
About Dorian Therapeutics
New therapeutics to rejuvenate tissue and treat age-related diseases
FAQ: Benedetta di Robilant net worth and Dorian Therapeutics valuation
What is Benedetta di Robilant's net worth?
Benedetta di Robilant's estimated net worth is $7.5M (range $5.25M – $11.25M) as of 2026. Benedetta di Robilant is Founder at Dorian Therapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Dorian Therapeutics valuation?
Dorian Therapeutics's estimated valuation on Entrepreneurial Check is $100.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Benedetta di Robilant's role?
Benedetta di Robilant is Founder at Dorian Therapeutics, a Y Combinator-backed startup (batch S18).